Giovanni Di Pasquale1, Beverly L Davidson2, 3, 4, Colleen S Stein2, Inês Martins2, Dominic Scudiero5, Anne Monks5
& John A Chiorini11
Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA.
2
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
3
Department of Neurology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
4
Department of Physiology & Biophysics, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
5
SAIC-Frederick, Frederick, Maryland 21702, USA.
Correspondence should be addressed to John A Chiorini Jchiorini@dir.nidcr.nih.gov
-polypeptide) and AAV-5 transduction. Subsequent experiments confirmed the role of PDGFR-
as receptors for AAV-5. The tropism of AAV-5 in vivo also correlated with the expression pattern of PDGFR-
